Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMDW) Return on Equity (2019 - 2025)

Historic Return on Equity for Revolution Medicines (RVMDW) over the last 7 years, with Q3 2025 value amounting to 0.56%.

  • Revolution Medicines' Return on Equity fell 2000.0% to 0.56% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.56%, marking a year-over-year decrease of 2000.0%. This contributed to the annual value of 0.29% for FY2024, which is 500.0% up from last year.
  • Per Revolution Medicines' latest filing, its Return on Equity stood at 0.56% for Q3 2025, which was down 2000.0% from 0.41% recorded in Q2 2025.
  • In the past 5 years, Revolution Medicines' Return on Equity ranged from a high of 0.2% in Q2 2021 and a low of 0.56% during Q3 2025
  • Its 5-year average for Return on Equity is 0.34%, with a median of 0.32% in 2025.
  • As far as peak fluctuations go, Revolution Medicines' Return on Equity surged by 3200bps in 2021, and later plummeted by -2200bps in 2022.
  • Quarter analysis of 5 years shows Revolution Medicines' Return on Equity stood at 0.3% in 2021, then fell by -21bps to 0.36% in 2022, then increased by 10bps to 0.33% in 2023, then grew by 4bps to 0.31% in 2024, then tumbled by -77bps to 0.56% in 2025.
  • Its Return on Equity stands at 0.56% for Q3 2025, versus 0.41% for Q2 2025 and 0.32% for Q1 2025.